Medications for Opioid Use Disorder (MOUD) is an umbrella term for medications used in the treatment of opioid addiction or opioid use disorder (OUD). These medications are typically prescribed as part of a comprehensive treatment program that also includes counseling and behavioral therapies.
There are three main types of medications used in MOUD:
Methadone: Methadone is a long-acting opioid agonist. It works by binding to the same receptors in the brain as opioids, such as heroin or prescription painkillers, but it does so in a way that helps to reduce cravings and withdrawal symptoms without producing the same euphoric effects. Methadone is usually dispensed in specialized clinics on a daily basis.
Buprenorphine: Buprenorphine is a partial opioid agonist, meaning it also binds to opioid receptors but produces weaker effects compared to full opioid agonists like heroin or methadone. Buprenorphine helps to reduce cravings and withdrawal symptoms while also blocking the effects of other opioids, which can help prevent relapse. It is often prescribed in the form of sublingual tablets or films and can be administered in a doctor’s office.
Naltrexone: Naltrexone is an opioid antagonist, meaning it blocks the effects of opioids by binding to the same receptors in the brain without activating them. Unlike methadone and buprenorphine, which help to reduce cravings and withdrawal symptoms, naltrexone works by preventing opioids from producing any effects if they are taken. It is available in both oral and injectable forms.
Research consistently supports the effectiveness of MOUD in reducing opioid use, preventing overdose, and enhancing overall well-being. Treatment should ideally be part of a comprehensive approach that includes counseling, behavioral therapies, and support services tailored to individual needs.
Medications for Opioid Use Disorder (MOUD) Resources
Websites
Medications for Substance Use Disorders
The SAMHSA webpage on Medications for Substance Use Disorders provides comprehensive information about FDA-approved medications used to treat substance use disorders, including opioids and alcohol.
Tools & Resources
Medications for Addiction Treatment (MAT) Resource Library
The MAT Resource Library is supported by the Los Angeles County Health Agency and Department of Public Health, Substance Abuse Prevention and Control. The site provides practical information on Medications for Addiction Treatment (MAT) for providers across health systems (e.g., physical health, mental health, and substance use disorder systems), as well as for patients.
Medication-Assisted Treatment (MAT) for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkit
This toolkit provides correctional administrators and health care providers recommendations and tools for implementing medication-assisted treatment (MAT) in correctional settings. It provides examples from the field that can be widely applied and adapted for programs that serve justice-involved individuals.
Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings
This guide focuses on using medication-assisted treatment for opioid use disorder in jails and prisons and during the reentry process when justice -involved persons return to the community. It provides an overview of policies and evidence-based practices that reduce the risk of overdose and relapse.
Medication-Assisted Treatment (MAT) for Opioid Use Disorder
SAMHSA offers a guide on MAT for opioid use disorder, which includes information on the various medications available for treatment, as well as resources for finding MAT providers and programs.
Medication for Opioid Use Disorder (MOUD) Toolkit for Peer Recovery Specialists
This toolkit is a resource for Peer Recovery Specialists (PRSs) to feel equipped to discuss MOUD with providers, people seeking recovery, and others with questions about this treatment option.
Publications
Medications for Opioid Use Disorder: An Effective Treatment for Justice-Involved Persons Reentering the Community Brief Reference Document
Medications for Opioid Use Disorder: An Effective Treatment for Justice-Involved Persons Reentering the Community Brief Reference Document explores how Opioid Use Disorder (OUD) treatment for justice-involved individuals will help lower the overdose risk for people reentering the community. It discusses treatment barriers, strategies to address them, and key reentry services to promote the successful reintegration of people returning to the community from incarceration.
Decisions in Recovery: Treatment for Opioid Use Disorders
This handbook provides guidance on using the web-based, multimedia tool Decisions in Recovery: Medications for Opioid Addiction. This handbook and the web-based tool offers information about medication-assisted treatment. Both resources help people living with opioid use disorder compare treatment options and discuss their preferences with a provider.
Medication-Assisted Treatment (MAT) Services for Opioid Dependence Billing Instructions Guide
The Division of Health Care Financing and Policy has taken action to address the opioid crisis by updating Nevada Medicaid policy and opening Medication-Assisted Treatment (MAT)-related evaluation and management (E/M) codes for billing by Nevada Medicaid providers effective with dates of service on or after January 1, 2020. In addition to MAT related E/M codes, Nevada Medicaid opened Screening, Brief Intervention, Referral to Treatment (SBIRT) codes to assist providers in performing screening services to recipients at risk or struggling with Substance Use Disorder (SUD).
Pocket Guide: Medication-Assisted Treatment of Opioid Use Disorders
This pocket guide is designed as a quick reference for information about medication-assisted treatment for opioid use disorder. It offers a checklist for prescribing medications to patients and provides a list of approved medications for treatment.
TIP 63: Medications for Opioid Use Disorder
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
The Patient-Centered Opioid Addiction Treatment (P-COAT) Model
P-COAT is an Alternative Payment Model designed by the American Medical Association (AMA) and The American Society of Addiction Medicine (ASAM). The P-COAT model was developed to expand access and utilization of medication assisted treatment (MAT) while also ensuring providers are appropriately reimbursed for the services they provide.
Posters & Infographics
Opioid Trifold Brochures
Opioid Information Brochures for Providers or Consumers help educate on opioids and opioid use, including effects of opioid use, pregnancy and opioid use, medications for opioid use including opioid overdose reversal medications, and treatment options for persons using opioids.
Download or request free hard copies
Medications for Opioid Use Disorder (MOUD) Infographic
This infographic shows different types of medications approved by the U.S. Food and Drug Administration for opioid overdose, withdrawal, and addiction.
Download the infographic
Webinars & Online Learning
Current News & Research
Buprenorphine Associated with Reduced Cannabis Use Compared to XR-Naltrexone in Patients Receiving Medications for Opioid Use Disorder
This NIDA study found that patients receiving buprenorphine for opioid use disorder used cannabis less frequently than those on extended-release naltrexone. The findings suggest that buprenorphine may have a moderating effect on cannabis use, which could have implications for treatment strategies.
Project AMPED
This is a multi-year, mixed methods study in Nevada and New Mexico is examining the patterns, reasons for, and health concerns related to methamphetamine use and opioid use.
Starting medication for opioid use disorder prior to prison release substantially reduces overdose deaths
Individuals with opioid use disorder being released from prison are at particularly high risk for fatal overdose, yet virtually no U.S. correctional facilities initiate or continue medications for addiction treatment that would protect people against overdose following release from prison. This study explored whether a novel program in the state of Rhode Island that continued inmates’ opioid use disorder medications led to decreased drug overdoses.